![[Roche vs Zydus] Apex Court Refuses To Revoke Injunction Against Sale Of Zydus Lifesciences' Breast Cancer Drug](https://i0.wp.com/lawchakra.in/wp-content/uploads/2024/11/Zydus-Lifesciences_-Zydus-barred-from-selling-cancer-biosimilar-for-now-The-Economic-Times.png?resize=420%2C315&ssl=1)
The Supreme Court on Monday(18th Nov) directed the Delhi High Court to swiftly resolve a patent dispute involving Zydus Lifesciences’ breast cancer drug, ‘Sigrima.’ Roche alleges patent infringement, with an interim injunction restraining Zydus from selling the drug. The Court emphasized the real-world impact of judicial decisions while maintaining the injunction until a December hearing.
The Delhi High Court fined Oppo Rs. 5 lakh in a patent dispute with InterDigital and warned of a potential sales ban if pending royalties aren’t deposited. The trial deadline is set for 2024, with more funds required if not met by December 2024. Oppo faces penalties for delays in court proceedings and infringement claims.
